Janmet Tablet 50 mg + 500 mg is a combination oral antidiabetic medicine containing Sitagliptin 50 mg and Metformin Hydrochloride 500 mg. It is prescribed for the management of Type 2 Diabetes Mellitus in adults when diet, exercise, and single-drug therapy do not provide adequate blood glucose control. This dual-action formulation helps improve glycemic control by addressing multiple underlying causes of high blood sugar.

Type 2 diabetes is a chronic metabolic disorder characterized by insulin resistance, decreased insulin secretion, and increased hepatic glucose production. Persistent high blood sugar can lead to serious complications such as heart disease, kidney damage, nerve problems, and vision impairment. Janmet Tablet helps reduce these risks by effectively lowering both fasting and post-meal blood glucose levels.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

Each film-coated tablet contains:

• Sitagliptin 50 mg (as Sitagliptin Phosphate)

• Metformin Hydrochloride 500 mg

Mechanism of Action

Janmet works through a complementary dual mechanism:

Sitagliptin is a DPP-4 (dipeptidyl peptidase-4) inhibitor. It increases the levels of incretin hormones (GLP-1 and GIP), which stimulate insulin release from pancreatic beta cells in a glucose-dependent manner and reduce glucagon secretion. This helps lower blood sugar, particularly after meals.

Metformin belongs to the biguanide class. It decreases hepatic glucose production (gluconeogenesis), reduces intestinal glucose absorption, and improves insulin sensitivity in peripheral tissues such as muscle. This leads to improved utilization of glucose and reduced fasting blood sugar levels.

Together, these two agents provide comprehensive blood glucose control without significantly increasing the risk of hypoglycemia when used alone.

Indications

Janmet Tablet 50 mg + 500 mg is indicated for:

• Management of Type 2 Diabetes Mellitus in adults

• Patients inadequately controlled with Metformin or Sitagliptin alone

• As part of combination therapy with other antidiabetic agents when necessary

It is not indicated for Type 1 diabetes or diabetic ketoacidosis.

Dosage and Administration

The dosage should be determined by a physician based on the patient’s glycemic status and current therapy. It is generally taken once or twice daily with meals to minimize gastrointestinal side effects associated with Metformin. Tablets should be swallowed whole with water and not crushed or chewed.

Regular monitoring of blood glucose levels and HbA1c is recommended during treatment.

Benefits

• Provides effective control of both fasting and postprandial blood glucose

• Combines two proven antidiabetic agents in one tablet

• Low risk of hypoglycemia when used alone

• Helps reduce long-term diabetic complications

• Convenient oral administration

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Precautions

• Use cautiously in patients with kidney or liver impairment

• Not recommended in severe renal dysfunction

• Monitor for signs of lactic acidosis (rare but serious with Metformin)

• Inform your doctor about all medications to avoid interactions

• Use during pregnancy or breastfeeding only under medical supervision

Possible Side Effects

Common side effects may include:

• Nausea, diarrhea, abdominal discomfort

• Headache

• Upper respiratory symptoms

• Rarely, hypoglycemia (especially when combined with insulin or sulfonylureas)

If severe symptoms such as persistent vomiting, muscle pain, breathing difficulty, or allergic reactions occur, seek medical attention immediately.